Insulin Analog [EPC]

202062 reported adverse events

Drugs of this class: INSULIN GLARGINE INSULIN LISPRO INSULIN DETEMIR INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 44454
1 BLOOD GLUCOSE DECREASED 11412
2 DRUG INEFFECTIVE 10099
3 NAUSEA 8751
4 HYPOGLYCAEMIA 7362
5 DRUG DOSE OMISSION 6758
6 INCORRECT DOSE ADMINISTERED 6688
7 MALAISE 6540
8 WEIGHT DECREASED 5908
9 VISUAL IMPAIRMENT 5613
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 837 0.9710
1 INTERCEPTED PRODUCT SELECTION ERROR 240 0.6138
2 HYPOGLYCAEMIA UNAWARENESS 178 0.6034
3 ANTI-INSULIN ANTIBODY POSITIVE 118 0.5930
4 HYPOGLYCAEMIC UNCONSCIOUSNESS 898 0.5720
5 BLOOD KETONE BODY 116 0.4979
6 HYPOGLYCAEMIC SEIZURE 329 0.4727
7 DIABETIC RETINOPATHY 823 0.4150
8 ACCIDENTAL UNDERDOSE 912 0.4095
9 SHOCK HYPOGLYCAEMIC 146 0.4000
See all enriched reactions for Insulin Analog [EPC]